Point-of-care blood analysis systems company Abaxis Inc. said the FDA granted waived status for its comprehensive metabolic panel, basic metabolic panel and electrolyte panel, allowing lab-accurate comprehensive health screenings in nearly any environment.
Four analytes for chloride (Cl-), potassium (K), sodium (Na) and total carbon dioxide (tCO2), were granted waived status by the FDA when used in conjunction with the Piccolo and Piccolo Xpress point-of-care analyzers.
The Abaxis CLIA waived menu of health panels now includes: a comprehensive metabolic panel, basic metabolic panel, electrolyte panel, kidney check, lipid panel, lipid panel plus, liver panel plus, general chemistry 6 and general chemistry 13.
February 2008
October 09, 2019 
